bosentan

Related by string. Bosentan * * bosentan Tracleer . Tracleer bosentan . Tracleer ® bosentan *

Related by context. All words. (Click for frequent words.) 71 tolvaptan 71 mitoxantrone 70 β blockers 70 tiotropium 69 candesartan 69 PREZISTA r 69 tocilizumab 69 FOLFOX4 69 ritonavir boosted 68 adalimumab 68 iloprost 68 tapentadol ER 68 octreotide LAR 68 tolterodine 68 DAPT 67 etanercept 67 FOLFIRI 67 teriparatide 67 chlorambucil 67 candesartan cilexetil 67 quetiapine 67 abciximab 67 fluvastatin 67 decitabine 67 VAPRISOL 67 GOUT 67 solifenacin 67 pramipexole 67 RLAI 67 prucalopride 67 tamsulosin 67 ATACAND 67 Pioglitazone 67 TRANSFORMS 67 ramipril 67 APTIVUS r 67 olmesartan 67 5-FU/LV 67 FOLFOX 67 vandetanib 67 desvenlafaxine succinate 67 virologic response 66 posaconazole 66 paricalcitol 66 azacitidine 66 diabetic neuropathic pain 66 ziprasidone 66 thromboembolic events 66 mycophenolate mofetil 66 aripiprazole 66 COPAXONE R 66 APTIVUS 66 ACE inhibitor ramipril 66 mRCC 66 oral rivaroxaban 66 CIMZIA TM 66 valsartan 66 mg dose 66 teriflunomide 66 vidofludimus 66 active comparator 66 NATRECOR R 66 CIMZIA ™ 66 vinorelbine 66 divalproex sodium 66 CIMZIA TM certolizumab pegol 66 daunorubicin 66 idraparinux 66 Ventavis 66 #mg BID [001] 66 riociguat 66 IFN beta 66 docetaxel chemotherapy 66 dosage regimens 66 Dasatinib 66 plus dexamethasone 66 tirofiban 66 adefovir 66 mg BID 66 lacosamide 66 abatacept 65 placebo controlled clinical 65 clodronate 65 salmeterol fluticasone 65 eltrombopag 65 dacarbazine 65 lopinavir r 65 oxycodone CR 65 bezafibrate 65 REMICADE ® 65 abacavir lamivudine 65 comparator arm 65 primary hypercholesterolemia 65 coadministration 65 NPH insulin 65 peginterferon alfa 2b 65 secondary efficacy endpoints 65 Ranolazine 65 oxcarbazepine 65 antihypertensive therapy 65 colesevelam HCl 65 ULORIC 65 gout flares 65 esomeprazole 65 beclomethasone dipropionate 65 elotuzumab 65 rFVIIa 65 pioglitazone 65 agomelatine 65 INC# 65 Fludara 65 Tolvaptan 65 pomalidomide 65 alvimopan 65 tipranavir 65 IFN α 65 allopurinol 65 monotherapy 65 INCB# [003] 65 ACTEMRA TM 65 PROMACTA 65 goserelin 65 achieved ACR# 65 4mg/kg 65 neurologic progression 65 oral FTY# 65 ramelteon 65 irbesartan 65 sunitinib malate 65 CANCIDAS 64 Bosentan 64 AVANDIA 64 rimonabant #mg 64 LEXIVA r 64 achieved statistical significance 64 beta blocker therapy 64 lumbar spine BMD 64 ACCOMPLISH 64 rosuvastatin 64 sitaxsentan 64 placebo controlled clinical trials 64 #mg dose [001] 64 cilostazol 64 mg kg dose 64 fluticasone salmeterol 64 octreotide 64 HBeAg positive patients 64 #mg doses [002] 64 placebo p = 64 6R BH4 64 insulin detemir 64 baminercept 64 analgesic efficacy 64 VIIBRYD 64 sunitinib 64 denufosol 64 anakinra 64 ibandronate 64 Natalizumab 64 ACTEMRA 64 dasatinib 64 efalizumab 64 pioglitazone HCl 64 #mg dose [003] 64 LEXIVA 64 amisulpride 64 metformin sulfonylurea 64 methotrexate MTX 64 eszopiclone 64 ischemic cardiomyopathy 64 AGILECT R 64 angiotensin converting enzyme inhibitors 64 Tasimelteon 64 SYMBICORT 64 ADHF 64 virologic failure 64 antiarrhythmic drugs 64 IIIa inhibitor 64 noninferiority 64 DMARD 64 aripiprazole Abilify 64 RRMS patients 64 icatibant 64 Telmisartan 64 virological failure 64 atazanavir ritonavir 64 CA4P 64 tanespimycin 64 certolizumab 64 zoledronic acid 64 tiotropium bromide 64 TACE 64 rHuPH# 64 biphasic insulin aspart 64 temsirolimus 64 OAB symptoms 64 RG# [001] 64 EFFEXOR XR 64 tolterodine ER 64 Tracleer R 64 Bortezomib 64 Lenalidomide 64 pimecrolimus 64 certolizumab pegol 64 losartan 64 morphometric vertebral fractures 64 metastatic RCC 64 deferiprone 64 treprostinil 64 sustained virologic response 64 flutamide 64 sorafenib Nexavar 64 INVEGA ® 64 rosuvastatin #mg 64 AZILECT R 64 darunavir ritonavir 64 tipranavir r 64 ranolazine 64 fondaparinux 64 glatiramer acetate 64 DOXIL 64 rotigotine 64 FROVA 64 dronedarone 64 Doxil ® 64 olanzapine 64 ciclesonide 64 brivaracetam 64 QD dosing 64 pregabalin 64 recurrent glioblastoma multiforme 63 eplerenone 63 canakinumab 63 Fludarabine 63 anastrozole 63 plus prednisone 63 Tiotropium 63 COPD exacerbations 63 liver histology 63 eculizumab therapy 63 EFAPROXYN 63 antithrombotic 63 beta 1a 63 doxazosin 63 glimepiride 63 angiotensin receptor blocker ARB 63 adriamycin 63 Traficet EN 63 Free Survival PFS 63 quetiapine XR 63 metastatic castration resistant 63 prospectively defined 63 adjunctive placebo 63 FASLODEX 63 Secondary endpoints 63 ruboxistaurin 63 KRAS mutant tumors 63 ARIXTRA 63 AGILECT ® 63 rizatriptan 63 dabigatran etexilate 63 citalopram 63 pentoxifylline 63 antiepileptic drugs AEDs 63 apremilast 63 sipuleucel T 63 peginterferon alfa 2a 63 BAY #-# 63 mcg BID 63 ximelagatran 63 Betaferon ® 63 telmisartan 63 nephrotoxicity 63 DMARDS 63 pyridostigmine 63 nab paclitaxel 63 non metastatic osteosarcoma 63 zolmitriptan 63 epoprostenol 63 dyslipidaemia 63 PXD# 63 carvedilol 63 diabetic gastroparesis 63 pertuzumab 63 multicentre randomized 63 viral kinetics 63 anticholinergics 63 FTY# 63 salmeterol HFA MDI 63 eosinophilic asthma 63 Valsartan 63 relapsed MM 63 tolerability 63 anti leukemic 63 adalimumab Humira 63 XELOX 63 ACZ# 63 HBeAg positive 63 VELCADE melphalan 63 5FU 63 paclitaxel eluting stents 63 hypomagnesemia 63 PRE SURGE 63 QTc 63 selegiline 63 visilizumab 63 antiemetics 63 plus ribavirin 63 NOXAFIL 63 Sandostatin LAR 63 mapatumumab 63 mg QD 63 febrile neutropenia 63 RoACTEMRA 63 nitazoxanide 63 antiarrhythmic drug 63 BOLDER 63 Monotherapy 63 nonrandomized 63 lamotrigine 63 pramlintide 63 Elitek 63 Protelos 63 MIRAPEX 63 HCV SPRINT 63 phenytoin 63 donepezil 63 mcg QD 63 zileuton 63 prednisone prednisolone 63 pulmonary arterial hypertension PAH 63 thromboembolic 63 HMG CoA reductase inhibitor 63 NATRECOR ® 63 pegylated liposomal doxorubicin 63 chemoradiation therapy 63 C1 INH 63 vorinostat 63 MADRS score 63 cinacalcet 63 ELACYT 63 cholinesterase inhibitors 63 ZD# [001] 63 dapagliflozin plus 63 MULTAQ 63 partial onset seizures 63 levetiracetam 63 milrinone 63 generalized anxiety disorder GAD 63 idarubicin 63 antimuscarinic 62 EVIZON 62 Atacand 62 xanthine oxidase inhibitor 62 PEGylated interferon beta 1a 62 inhibitor RG# 62 oral diclofenac 62 Acute Ischemic Stroke 62 cediranib 62 nicardipine 62 cabazitaxel 62 Adalimumab 62 HCV RESPOND 2 62 DMARDs 62 dopamine partial agonist 62 XIENCE V PROMUS Stent 62 unfractionated heparin 62 lipid lowering therapy 62 iniparib 62 Ranibizumab 62 PEGylated Fab fragment 62 budesonide 62 lispro 62 fenofibric acid 62 BOLDER II 62 velafermin 62 ancrod 62 Thal Dex 62 PRISTIQ 62 interferon gamma 1b 62 galiximab 62 KAPIDEX 62 azacytidine 62 FOSRENOL ® 62 APPRAISE 62 risperidone 62 EURIDIS 62 inotropic 62 pegaptanib 62 Pegasys ® 62 axitinib 62 ACEIs 62 HBeAg negative patients 62 uric acid lowering 62 vicriviroc 62 CsA 62 DU #b 62 RE LY ® 62 T2DM 62 low dose cytarabine 62 strontium ranelate 62 venlafaxine XR 62 Newly Diagnosed Multiple Myeloma 62 interferon alfa 2b 62 ambrisentan 62 complete cytogenetic response 62 neuroleptics 62 hydroxymethyl coenzyme 62 tolerability profiles 62 relapsing remitting multiple sclerosis 62 weekly subcutaneous injections 62 afatinib 62 μmol L 62 insulin glargine 62 crizotinib PF # 62 haloperidol Haldol 62 Peg IFN 62 nilotinib 62 pimozide 62 clazosentan 62 Femara letrozole 62 risperidone Risperdal 62 QVAR R 62 SEROQUEL 62 entecavir 62 docetaxel Taxotere ® 62 AVODART 62 systemic corticosteroid 62 HoFH 62 methotrexate monotherapy 62 typical antipsychotics 62 Randomized Phase 62 Perforomist Inhalation Solution 62 steroid dexamethasone 62 PEG IFN 62 carboplatin paclitaxel 62 HMG CoA reductase inhibitors 62 antiretroviral naive 62 peginterferon 62 OADs 62 VIRAMUNE 62 TNF inhibitors 62 prospective randomized controlled 62 AZT zidovudine Retrovir 62 nortriptyline 62 lanthanum carbonate 62 pimecrolimus cream 62 fingolimod 62 TAXOTERE R 62 zonisamide SR 62 alpha blocker 62 stable angina 62 somatostatin analog 62 direct thrombin inhibitors 62 NEXIUM 62 DMARD therapy 62 rilonacept 62 ribavirin therapy 62 clopidogrel Plavix 62 TORISEL 62 8mg/kg 62 ZYVOX 62 serum phosphorus 62 phosphate binders 62 pharmacokinetic PK 62 placebo controlled trials 62 ivabradine 62 free survival PFS 62 postmenopausal osteoporotic women 62 recurrent GBM 62 BENICAR HCT 62 LY# [003] 62 refractory NSCLC 62 sorafenib tablets 62 alteplase 62 metabolic parameters 62 hypercalcemia 62 intermittent dosing 62 INCB# [001] 62 estramustine 62 mg TID 62 Oral Fingolimod 62 left ventricular dysfunction 62 alfuzosin 62 CR nPR 62 plus gemcitabine 62 ketoconazole 62 hepatotoxicity 62 Cimzia ® 62 serum phosphate levels 62 ARIMIDEX 62 dalfampridine 62 hydroxychloroquine 62 atorvastatin #mg 62 pegylated interferons 62 extrapyramidal symptoms 62 inhaled iloprost 62 romiplostim 62 boosted protease inhibitor 62 adjunctive ABILIFY 62 lupus nephritis 62 Carvedilol 62 thiazide diuretic 62 Teriparatide 62 XGEVA 62 Lamotrigine 62 TAXUS Stent 62 ORENCIA ® 62 tranylcypromine 62 thrombotic events 62 gemifloxacin 62 sapacitabine 62 alvespimycin 62 Avanafil 62 tacrolimus ointment 62 Metoprolol 62 venous thromboembolic events 62 fosbretabulin 62 dexrazoxane 62 CaPre TM 62 ABC/3TC 62 edoxaban 62 NYHA class 62 intravesical 62 nonresponders 62 angiotensin converting enzyme ACE 62 ZOLINZA 62 mildly symptomatic 62 SVR# 62 Xanafide 61 plus methotrexate 61 selective modulator 61 dosing regimens 61 subcutaneous insulin 61 fluticasone furoate 61 ALVESCO 61 sotalol 61 lipid lowering agents 61 interferon alfa 61 GAMMAGARD 61 ribavirin RBV 61 Ramipril 61 Vaprisol 61 TNF inhibitor 61 recurrent VTE 61 AZILECT 61 everolimus eluting stents 61 stage IIIB 61 diarrhea predominant irritable 61 erlotinib Tarceva ® 61 primidone 61 ISIS # 61 mu opioid receptor antagonist 61 #.#mg/dL 61 Torisel 61 #mg/day [001] 61 glufosfamide 61 evaluating tivozanib 61 hypogonadal men 61 LMWH 61 lipid parameters 61 zalutumumab 61 dacarbazine DTIC 61 active ankylosing spondylitis 61 mcg dose 61 tenofovir emtricitabine 61 eculizumab 61 Bevacizumab 61 dalteparin 61 bronchodilation 61 EDARBI 61 bendamustine 61 FOLPI 61 bexarotene 61 Controlled Trial 61 MERLIN TIMI 61 PASI scores 61 PegIntron 61 refractory gout 61 ARCOXIA 61 STN stimulation 61 TMC# r 61 aldosterone antagonists 61 fluorouracil 61 LAMICTAL 61 virological response 61 palonosetron 61 interferon ribavirin 61 mCRC patients 61 #mg QD [001] 61 LUX Lung 61 indinavir 61 esophageal candidiasis 61 NUVIGIL 61 IFN alfa 61 Diabetic Macular Edema 61 sorafenib 61 CYPHER R Sirolimus eluting 61 RLS symptoms 61 serum phosphate 61 Teriflunomide 61 Ophena TM 61 metastatic renal cell carcinoma 61 dose regimens 61 anxiolytic 61 Toxicities 61 clozapine 61 discontinuations due 61 TOPAMAX 61 mixed hyperlipidemia 61 leukopenia 61 budesonide formoterol 61 corticosteroid therapy 61 verapamil 61 biologic therapy 61 Pivotal Phase 61 ropinirole 61 PREZISTA ritonavir 61 guanfacine 61 STRIDE PD 61 inhaled corticosteroid 61 titrated glipizide 61 glargine 61 invasive candidiasis 61 PAOD 61 PD LID 61 sertraline Zoloft 61 ONTARGET 61 relapsing MS 61 oral antidiabetic medication 61 oxybutynin 61 anti TNF 61 CYPHER Stent 61 PSN# [002] 61 cangrelor 61 hour bronchodilation 61 pioglitazone Actos 61 TNF Tumor Necrosis Factor 61 Hydroxyurea 61 preoperative chemotherapy 61 nadolol 61 oral allopurinol 61 celecoxib 61 TYKERB 61 Pegylated Liposomal Doxorubicin 61 Bronchitol 61 hematologic toxicity 61 forodesine 61 intermittent claudication 61 oblimersen 61 subclinical hypothyroidism 61 PEGylated anti 61 atherothrombotic events 61 virologic 61 dyskinesia PD LID 61 PRT# 61 Fibrillex TM 61 metastatic HRPC 61 conventional antipsychotics 61 R# #mg BID 61 mecamylamine 61 febuxostat 61 Keppra R 61 ticagrelor 61 Tarceva erlotinib 61 lipid lowering drugs 61 #mg BID [003] 61 BIBW 61 CONCERTA 61 QTc prolongation 61 Dapagliflozin 61 fenofibrate 61 safinamide 61 Aclidinium 61 lopinavir r arm 61 severe exacerbations 61 systemic corticosteroids 61 oral anticoagulation 61 platelet inhibitor 61 gemcitabine 61 pharmacodynamic PD 61 fosamprenavir 61 Candesartan 61 PsA 61 painful diabetic neuropathy 61 pharmacodynamic profile 61 davunetide intranasal AL 61 biologic DMARD 61 Targretin 61 iodixanol 61 Betaferon R 61 FFNS 61 metastatic malignant 61 bicalutamide 61 maximally tolerated dose 61 thrombocytopenic 61 nucleoside analog 61 Tavocept 61 chemoradiotherapy 61 clomipramine 61 infliximab 61 metformin HCl 61 tadalafil Cialis 61 LT NS# 61 Flu Cy 61 ARCALYST 61 amlodipine 61 Losartan 61 benazepril 61 intravenous bisphosphonates 61 dual endothelin receptor antagonist 61 Pemetrexed 61 TELCYTA 61 TNF antagonist 61 ziprasidone Geodon 61 Onbrez Breezhaler 61 raltegravir 61 Ziprasidone 61 HbA1c levels 61 COZAAR 61 alfa 2a 61 androgen deprivation 61 pegylated interferon alfa 2a 61 Copegus ribavirin 61 telcagepant 61 GnRH agonist 61 cardiac toxicity 61 Multaq R 61 Quetiapine 61 TNF antagonists 61 timolol 61 hyperphenylalaninemia HPA due 61 SCH # 61 COPAXONE ® 61 MabCampath 61 cardiovascular morbidity 61 Navelbine ® 61 COREG 61 composite endpoint 61 tasocitinib 61 BARACLUDE ® 61 ADAGIO study 61 Denufosol 61 INTEGRILIN R 61 virologic breakthrough 61 placebo controlled Phase III 61 genotypic resistance 61 eptifibatide 61 telaprevir dosed 61 Lantus ® 61 Azacitidine 61 CCyR 61 chronic thromboembolic pulmonary 61 NRTIs 61 Neovascular AMD 61 concomitant medications 61 potassium sparing diuretics 61 piperacillin tazobactam 61 castration resistant prostate cancer 61 double blinded placebo 61 nondiabetic patients 61 NRTI 61 fluoxetine 61 bisoprolol 61 rhGH 61 BRIM2 61 Ticagrelor 61 PEGINTRON TM 61 latanoprost 61 antioxidant supplementation 61 EXJADE 61 Capecitabine 60 angiotensin converting enzyme inhibitor 60 IRESSA 60 HuMax EGFr 60 Northera 60 Phase 2a trial 60 dyspnea 60 T1DM 60 splenectomized patients 60 esomeprazole Nexium 60 mGluR5 NAM 60 micafungin 60 ARB telmisartan 60 unresectable stage 60 fulvestrant 60 peginterferon alfa 60 NMDA antagonists 60 infusional 5-FU/LV 60 pharmacokinetic interactions 60 REYATAZ R 60 liposome injection 60 glitazones 60 urate lowering 60 cilengitide 60 SEROQUEL R 60 LYSTEDA 60 lapatinib Tykerb 60 Aptivus ® 60 events AEs 60 APTIVUS ritonavir 60 RISPERDAL ® 60 Golimumab 60 median PFS 60 fluticasone 60 ofatumumab 60 trials RCTs 60 adenoma recurrence 60 gefitinib 60 LPV r 60 relapsed CLL 60 pramlintide metreleptin combination 60 calcineurin inhibitor 60 dosing cohort 60 lenalidomide dexamethasone 60 Abilify aripiprazole 60 atazanavir 60 leukotriene receptor antagonist 60 AA Amyloidosis 60 cariprazine 60 colorectal liver metastases 60 PRADAXA 60 TEAEs 60 subcutaneously administered 60 HER2 positive metastatic breast 60 LVEF 60 cetuximab Erbitux R 60 efficacy tolerability 60 DDP# 60 invasive aspergillosis 60 secondary endpoint 60 IV NSCLC 60 panobinostat 60 FOLFOX6 60 ziconotide 60 orthostatic hypotension 60 INTELENCE 60 β blocker 60 oral prodrug 60 donepezil Aricept 60 abiraterone acetate 60 rufinamide 60 RE LY 60 renal insufficiency 60 antithrombotic therapy 60 sirolimus eluting stent 60 Trastuzumab 60 pemetrexed 60 pharmacokinetic profiles 60 relapsing multiple sclerosis 60 Adenoma Prevention 60 mg doses 60 rabeprazole 60 imatinib therapy 60 H. pylori eradication 60 potent CYP#A# inhibitors 60 mirtazapine 60 Ventavis ® 60 arterial thrombosis 60 ExTRACT TIMI 60 Fulvestrant 60 MoxDuo IR 60 receiving golimumab 60 TMC# [001] 60 dual antiplatelet therapy 60 HuLuc# 60 lipid lowering therapies 60 DEFINITY ® 60 sorafenib Nexavar ® 60 CTEPH 60 cytopenias 60 heavily pretreated 60 MIRAPEX ER 60 USL# 60 reinfarction 60 protease inhibitor PI 60 GW# [003] 60 balsalazide 60 subgroup analyzes 60 exemestane 60 glycopyrrolate 60 CDK inhibitor 60 antiarrhythmic 60 Eltrombopag 60 pegylated interferon alfa 2b 60 evaluable 60 plasma uric acid 60 BYSTOLIC 60 platelet inhibition 60 Amrubicin 60 FluCAM 60 unfractionated heparin UFH 60 salmeterol 60 TELINTRA 60 DLTs 60 aprepitant 60 dutasteride 60 statistically significant p = 60 HuMax CD# 60 lomitapide 60 #mg/day [002] 60 claudication 60 sevelamer 60 Phase Ib clinical 60 pulmonary exacerbations 60 Welchol 60 paroxetine Paxil 60 standard chemotherapy regimen 60 racemic albuterol 60 Lamictal XR 60 LTRA 60 placebo controlled Phase 60 TDF FTC 60 Kaplan Meier analysis 60 rFIXFc 60 phase IIa clinical 60 REYATAZ r arm 60 pegylated interferon alfa 60 thienopyridine 60 Darusentan 60 Abatacept 60 phase IIIb 60 gemcitabine carboplatin 60 nocturia 60 serum urate 60 intravitreal injection 60 relapsed myeloma 60 leukotriene receptor antagonists 60 leukemia AML 60 sirolimus eluting stents 60 ularitide 60 phase IIb clinical 60 macrovascular 60 placebo controlled randomized 60 MGd 60 P = .# 60 calcineurin inhibitors 60 pazopanib 60 baseline HbA1c 60 caspofungin 60 levosimendan 60 PREZISTA rtv 60 montelukast 60 fostamatinib 60 LUTS 60 erythropoietic 60 neuroleptic 60 oral vancomycin 60 severe neutropenia 60 Tolerability 60 interferon alfa 2a 60 BEACOPP 60 AZOR 60 Genz # 60 Myelodysplastic Syndrome MDS 60 Tocilizumab 60 Abciximab 60 inhaled treprostinil 60 pamidronate 60 zoledronate 60 3TC lamivudine Epivir 60 Allergic Rhinitis 60 vildagliptin 60 trospium 60 odanacatib 60 placebo controlled studies 60 superficial bladder cancer 60 rosuvastatin Crestor 60 Peginterferon Alfa 2a 60 INVEGA R 60 anti arrhythmic drug 60 tolerability profile 60 Bezielle 60 MAP# 60 postoperative AF 60 lumiliximab 60 Taxotere ® 60 tricyclic antidepressants 60 relapsed multiple myeloma 60 Pharmacokinetics PK 60 dose cytarabine 60 HGS ETR2 60 rasagiline 60 EOquin TM 60 primary efficacy endpoints 60 metformin monotherapy 60 CIMZIA R 60 intravenous cyclophosphamide 60 PANSS scores 60 renal toxicity 60 dextromethorphan quinidine 60 trabectedin 60 docetaxel prednisone 60 lumiracoxib 60 nonvertebral fractures 60 ezetimibe simvastatin 60 Certolizumab pegol 60 inhaled budesonide 60 GLIADEL R Wafer

Back to home page